{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:43:48Z","timestamp":1789681428204,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M653719"],"award-info":[{"award-number":["2019M653719"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2021JQ-459"],"award-info":[{"award-number":["2021JQ-459"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971586"],"award-info":[{"award-number":["81971586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871417"],"award-info":[{"award-number":["81871417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072063, 31901003"],"award-info":[{"award-number":["82072063, 31901003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22072115"],"award-info":[{"award-number":["22072115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150301"],"award-info":[{"award-number":["82150301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313919"],"award-info":[{"award-number":["2018A030313919"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-022-00975-2","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T12:31:45Z","timestamp":1671453105000},"page":"221-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging"],"prefix":"10.1038","volume":"7","author":[{"given":"Huan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon-Huat","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-772X","authenticated-orcid":false,"given":"Haiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"975_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"B Freddie","year":"2018","unstructured":"Freddie, B. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"975_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner, A., Reig, M. & Bruix, J. Hepatocellular carcinoma. Lancet 391, 1301\u20131314 (2018).","journal-title":"Lancet"},{"key":"975_CR3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"key":"975_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales, J. M. et al. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"975_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi, S. et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 15, 95\u2013111 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"975_CR6","doi-asserted-by":"crossref","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2019","unstructured":"Anwanwan, D. et al. Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer 1873, 188314 (2019).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"975_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21161","volume":"62","author":"M Maluccio","year":"2012","unstructured":"Maluccio, M. & Covey, A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J. Clin. 62, 394\u2013399 (2012).","journal-title":"CA Cancer J. Clin."},{"key":"975_CR8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.14131996","volume":"271","author":"MH Yu","year":"2014","unstructured":"Yu, M. H. et al. Small (\u22641 cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology 271, 748\u2013760 (2014).","journal-title":"Radiology"},{"key":"975_CR9","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Hepatobiliary Cancer Version.1 (NCCN, 2018)."},{"key":"975_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver.","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guideline: management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236 (2018).","journal-title":"J. Hepatol."},{"key":"975_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1148\/radiol.14132361","volume":"272","author":"JY Choi","year":"2014","unstructured":"Choi, J. Y., Lee, J. M. & Sirlin, C. B. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects. Radiology 272, 635\u2013654 (2014).","journal-title":"Radiology"},{"key":"975_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1148\/radiol.14132362","volume":"273","author":"JY Choi","year":"2014","unstructured":"Choi, J. Y., Lee, J. M. & Sirlin, C. B. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273, 30\u201350 (2014).","journal-title":"Radiology"},{"key":"975_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","volume":"57","author":"BEV Beers","year":"2012","unstructured":"Beers, B. E. V., Pastor, C. M. & Hussain, H. K. Primovist, eovist: what to expect? J. Hepatol. 57, 421\u2013429 (2012).","journal-title":"J. Hepatol."},{"key":"975_CR14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2015.11.016","volume":"64","author":"V Vilgrain","year":"2016","unstructured":"Vilgrain, V., Beers, B. E. V. & Pastor, C. M. Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI. J. Hepatol. 64, 708\u2013716 (2016).","journal-title":"J. Hepatol."},{"key":"975_CR15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nnano.2016.72","volume":"11","author":"P Mi","year":"2016","unstructured":"Mi, P. et al. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. Nat. Nanotechnol. 11, 724\u2013730 (2016).","journal-title":"Nat. Nanotechnol."},{"key":"975_CR16","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1021\/acs.jmedchem.6b01799","volume":"60","author":"MK Islam","year":"2017","unstructured":"Islam, M. K. et al. Manganese complex of ethylenediaminetetraacetic acid (EDTA)-benzothiazole aniline (BTA) conjugate as a potential liver-targeting MRI contrast agent. J. Med. Chem. 60, 2993\u20133001 (2017).","journal-title":"J. Med. Chem."},{"key":"975_CR17","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1021\/acs.jmedchem.8b00964","volume":"61","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Manganese-based contrast agents for magnetic resonance imaging of liver tumors: structure-activity relationships and lead candidate evaluation. J. Med. Chem. 61, 8811\u20138824 (2018).","journal-title":"J. Med. Chem."},{"key":"975_CR18","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/acs.bioconjchem.8b00560","volume":"29","author":"MK Islam","year":"2018","unstructured":"Islam, M. K. et al. Synthesis and evaluation of manganese (II)-Based ethylenediaminetetraacetic acid-ethoxybenzyl conjugate as a highly stable hepatobiliary magnetic resonance imaging contrast agent. Bioconjug. Chem. 29, 3614\u20133625 (2018).","journal-title":"Bioconjug. Chem."},{"key":"975_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiol.2020192713","volume":"295","author":"M-J Kim","year":"2020","unstructured":"Kim, M.-J. Improving survival with gadoxetic acid-enhanced MRI for hepatocellular carcinoma. Radiology 295, 125\u2013126 (2020).","journal-title":"Radiology"},{"key":"975_CR20","first-page":"149","volume":"274","author":"DH Lee","year":"2014","unstructured":"Lee, D. H. et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Radiology 274, 149\u2013160 (2014).","journal-title":"Radiology"},{"key":"975_CR21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1148\/radiol.2016151061","volume":"281","author":"M Okada","year":"2016","unstructured":"Okada, M. et al. Biochemical and clinical predictive approach and time point analysis of hepatobiliary phase liver enhancement on Gd-EOB-DTPA-enhanced MR images: a multicenter study. Radiology 281, 474\u2013483 (2016).","journal-title":"Radiology"},{"key":"975_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1148\/radiol.2020190639","volume":"295","author":"TW Kang","year":"2020","unstructured":"Kang, T. W. et al. Use of gadoxetic acid-enhanced liver MRI and mortality in more than 30\u2009000 patients with hepatocellular carcinoma: a nationwide analysis. Radiology 295, 114\u2013124 (2020).","journal-title":"Radiology"},{"key":"975_CR23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1148\/radiol.2017170977","volume":"286","author":"EM Gale","year":"2018","unstructured":"Gale, E. M. et al. A manganese-based alternative to gadolinium: contrast-enhanced MR angiography, excretion, pharmacokinetics, and metabolism. Radiology 286, 865\u2013872 (2018).","journal-title":"Radiology"},{"key":"975_CR24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","volume":"119","author":"Wahsner, J","year":"2019","unstructured":"Wahsner, J. et al. Chemistry of MRI contrast agents: current challenges and new frontiers. Chem. Rev. 119, 957\u20131057 (2019).","journal-title":"Chem. Rev."},{"key":"975_CR25","doi-asserted-by":"crossref","first-page":"17014","DOI":"10.1038\/natrevmats.2017.14","volume":"2","author":"SM Park","year":"2017","unstructured":"Park, S. M. et al. Towards clinically translatable in vivo nanodiagnostics. Nat. Rev. Mater. 2, 17014 (2017).","journal-title":"Nat. Rev. Mater."},{"key":"975_CR26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"975_CR27","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"975_CR28","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi, K. M. et al. Mechanism of hard-nanomaterial clearance by the liver. Nat. Mater. 15, 1212\u20131221 (2016).","journal-title":"Nat. Mater."},{"key":"975_CR29","doi-asserted-by":"crossref","first-page":"13400","DOI":"10.3748\/wjg.v21.i47.13400","volume":"21","author":"YXJ Wang","year":"2015","unstructured":"Wang, Y. X. J. Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging. World J. Gastroenterol. 21, 13400\u201313402 (2015).","journal-title":"World J. Gastroenterol."},{"key":"975_CR30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41551-017-0116-7","volume":"1","author":"Y Lu","year":"2017","unstructured":"Lu, Y. et al. Iron oxide nanoclusters for T1 magnetic resonance imaging of non-human primates. Nat. Biomed. Eng. 1, 637\u2013643 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"975_CR31","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja203340u","volume":"133","author":"BH Kim","year":"2011","unstructured":"Kim, B. H. et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 133, 12624\u201312631 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"975_CR32","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1620145114","volume":"114","author":"H Wei","year":"2017","unstructured":"Wei, H. et al. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents. Proc. Natl Acad. Sci. USA 114, 2325\u20132330 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"975_CR33","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/acsnano.6b07684","volume":"11","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Ultrasmall ferrite nanoparticles synthesized via dynamic simultaneous thermal decomposition for high-performance and multifunctional T1 magnetic resonance imaging contrast agent. ACS Nano 11, 3614\u20133631 (2017).","journal-title":"ACS Nano"},{"key":"975_CR34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.7150\/thno.31233","volume":"9","author":"Y Miao","year":"2019","unstructured":"Miao, Y. et al. Composition-tunable ultrasmall manganese ferrite nanoparticles: insights into their in vivo T1 contrast efficacy. Theranostics 9, 1764\u20131776 (2019).","journal-title":"Theranostics"},{"key":"975_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11601","volume":"7","author":"K Tuschl","year":"2016","unstructured":"Tuschl, K. et al. Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat. Commun. 7, 11601 (2016).","journal-title":"Nat. Commun."},{"key":"975_CR36","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1038\/celldisc.2017.25","volume":"3","author":"Y Xin","year":"2017","unstructured":"Xin, Y. et al. Manganese transporter slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice. Cell Discov. 3, 17025 (2017).","journal-title":"Cell Discov."},{"key":"975_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s007750100290","volume":"7","author":"PP Schmidt","year":"2002","unstructured":"Schmidt, P. P. et al. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR. J. Biol. Inorg. Chem. 7, 241\u2013248 (2002).","journal-title":"J. Biol. Inorg. Chem."},{"key":"975_CR38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0731-7085(96)01944-9","volume":"15","author":"KG Toft","year":"1997","unstructured":"Toft, K. G. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharm. Biomed. Anal. 15, 983\u2013988 (1997). 1997.","journal-title":"J. Pharm. Biomed. Anal."},{"key":"975_CR39","doi-asserted-by":"crossref","first-page":"1300069","DOI":"10.1002\/admi.201300069","volume":"1","author":"XL Liu","year":"2014","unstructured":"Liu, X. L. et al. Coating engineering of MnFe2O4 nanoparticles with superhigh T2 relaxivity and efficient cellular uptake for highly sensitive magnetic resonance imaging. Adv. Mater. Interfaces 1, 1300069 (2014).","journal-title":"Adv. Mater. Interfaces"},{"key":"975_CR40","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1021\/ja1084095","volume":"133","author":"T Kim","year":"2011","unstructured":"Kim, T. et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 133, 2955\u20132961 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"975_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2013.01.032","volume":"62","author":"EJ Martinez-Finley","year":"2013","unstructured":"Martinez-Finley, E. J. et al. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic. Biol. Med. 62, 65\u201375 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"975_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40572-015-0056-x","volume":"2","author":"SL O\u2019Neal","year":"2015","unstructured":"O\u2019Neal, S. L. & Zheng, W. Manganese toxicity upon overexposure: a decade in review. Curr. Environ. Health Rep. 2, 315\u2013328 (2015).","journal-title":"Curr. Environ. Health Rep."},{"key":"975_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1148\/radiology.218.1.r01ja2427","volume":"218","author":"RC Semelka","year":"2001","unstructured":"Semelka, R. C. & Helmberger, T. K. G. Contrast agents for MR imaging of the liver. Radiology 218, 27\u201338 (2001).","journal-title":"Radiology"},{"key":"975_CR44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","volume":"14","author":"P Reimer","year":"2004","unstructured":"Reimer, P., Schneider, G. & Schima, W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur. Radiol. 14, 559\u2013578 (2004).","journal-title":"Eur. Radiol."},{"key":"975_CR45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.biomaterials.2013.10.029","volume":"35","author":"A Ketkar-Atre","year":"2014","unstructured":"Ketkar-Atre, A. et al. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes. Biomaterials 35, 1015\u20131024 (2014).","journal-title":"Biomaterials"},{"key":"975_CR46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.biomaterials.2006.09.014","volume":"28","author":"KM Kamruzzaman Selim","year":"2007","unstructured":"Kamruzzaman Selim, K. M. et al. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 28, 710\u2013716 (2007).","journal-title":"Biomaterials"},{"key":"975_CR47","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1021\/acsami.8b17162","volume":"11","author":"D Pich\u00e9","year":"2019","unstructured":"Pich\u00e9, D. et al. Targeted T1 magnetic resonance imaging contrast enhancement with extraordinarily small CoFe2O4 nanoparticles. ACS Appl. Mater. Interfaces 11, 6724\u20136740 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"975_CR48","doi-asserted-by":"crossref","first-page":"E1769","DOI":"10.1073\/pnas.1720739115","volume":"115","author":"S Jenkitkasemwong","year":"2018","unstructured":"Jenkitkasemwong, S. et al. SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice. Proc. Natl Acad. Sci. USA 115, E1769\u2013E1778 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"975_CR49","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1074\/jbc.RA119.008762","volume":"294","author":"IF Scheiber","year":"2019","unstructured":"Scheiber, I. F., Wu, Y., Morgan, S. E. & Zhao, N. The intestinal metal transporter ZIP14 maintains systemic manganese homeostasis. J. Biol. Chem. 294, 9147\u20139160 (2019).","journal-title":"J. Biol. Chem."},{"key":"975_CR50","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","volume":"13","author":"W Poon","year":"2019","unstructured":"Poon, W. et al. Elimination pathways of nanoparticles. ACS Nano 13, 5785\u20135798 (2019).","journal-title":"ACS Nano"},{"key":"975_CR51","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","volume":"117","author":"M Srinivasarao","year":"2017","unstructured":"Srinivasarao, M. & Low, P. S. Ligand-targeted drug delivery. Chem. Rev. 117, 12133\u201312164 (2017).","journal-title":"Chem. Rev."},{"key":"975_CR52","doi-asserted-by":"crossref","first-page":"731089","DOI":"10.1100\/2012\/731089","volume":"2012","author":"M Bilgin","year":"2012","unstructured":"Bilgin, M. et al. Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the biliary obstruction. Sci. World J. 2012, 731089 (2012).","journal-title":"Sci. World J."},{"key":"975_CR53","doi-asserted-by":"crossref","first-page":"W49","DOI":"10.2214\/AJR.12.9332","volume":"201","author":"CS Reiner","year":"2013","unstructured":"Reiner, C. S. et al. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography? AJR Am. J. Roentgenol. 201, W49\u2013W56 (2013).","journal-title":"AJR Am. J. Roentgenol."},{"key":"975_CR54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jvir.2010.01.012","volume":"21","author":"WEA Saad","year":"2010","unstructured":"Saad, W. E. A. et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J. Vasc. Interv. Radiol. 21, 789\u2013795 (2010).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"975_CR55","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.2018172424","volume":"289","author":"BS Kapoor","year":"2018","unstructured":"Kapoor, B. S., Mauri, G. & Lorenz, J. M. Management of biliary strictures: state-of-the-art review. Radiology 289, 590\u2013603 (2018).","journal-title":"Radiology"},{"key":"975_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0016-5107(04)02463-0","volume":"61","author":"ML Freeman","year":"2005","unstructured":"Freeman, M. L. & Guda, N. M. ERCP cannulation: a review of reported techniques. Gastrointest. Endosc. 61, 112\u2013125 (2005).","journal-title":"Gastrointest. Endosc."},{"key":"975_CR57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(00)02479-X","volume":"356","author":"HE Adamek","year":"2000","unstructured":"Adamek, H. E. et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 356, 190\u2013193 (2000).","journal-title":"Lancet"},{"key":"975_CR58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nnano.2012.74","volume":"7","author":"L Ye","year":"2012","unstructured":"Ye, L. et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat. Nanotechnol. 7, 453\u2013458 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"975_CR59","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1021\/acsnano.7b05377","volume":"11","author":"PA Chiarelli","year":"2017","unstructured":"Chiarelli, P. A. et al. Nanoparticle biokinetics in mice and nonhuman primates. ACS Nano 11, 9514\u20139524 (2017).","journal-title":"ACS Nano"},{"key":"975_CR60","first-page":"35","volume":"1","author":"YXJ Wang","year":"2011","unstructured":"Wang, Y. X. J. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant. Imaging Med. Surg. 1, 35\u201340 (2011).","journal-title":"Quant. Imaging Med. Surg."},{"key":"975_CR61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2214\/AJR.10.4394","volume":"196","author":"JE Kim","year":"2011","unstructured":"Kim, J. E., Kim, S. H., Lee, S. J. & Rhim, H. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am. J. Roentgenol. 196, 758\u2013765 (2011).","journal-title":"AJR Am. J. Roentgenol."},{"key":"975_CR62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00261-014-0180-3","volume":"40","author":"R Faletti","year":"2015","unstructured":"Faletti, R. et al. Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation. Abdom. Imaging 40, 46\u201355 (2015).","journal-title":"Abdom. Imaging"},{"key":"975_CR63","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1002\/adma.201304744","volume":"26","author":"J Zeng","year":"2014","unstructured":"Zeng, J. et al. Anchoring group effects of surface ligands on magnetic properties of Fe3O4 nanoparticles: towards high performance MRI contrast agents. Adv. Mater. 26, 2694\u20132698 (2014).","journal-title":"Adv. Mater."},{"key":"975_CR64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.2016150361","volume":"280","author":"P Bize","year":"2016","unstructured":"Bize, P. et al. Antitumoral effect of sunitinib-eluting beads in the rabbit VX2 tumor model. Radiology 280, 425\u2013435 (2016).","journal-title":"Radiology"},{"key":"975_CR65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/RLI.0b013e3181ed55b4","volume":"45","author":"JM Chang","year":"2010","unstructured":"Chang, J. M. et al. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model. Invest. Radiol. 45, 655\u2013661 (2010).","journal-title":"Invest. Radiol."},{"key":"975_CR66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejrad.2011.03.009","volume":"81","author":"H Shao","year":"2012","unstructured":"Shao, H. et al. Diffusion-weighted MR imaging allows monitoring the effect of combretastatin A4 phosphate on rabbit implanted VX2 tumor model: 12-day dynamic results. Eur. J. Radiol. 81, 578\u2013583 (2012).","journal-title":"Eur. J. Radiol."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00975-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:15:40Z","timestamp":1679670940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00975-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1038\/s41551-022-00975-2","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}